rs3785905

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002734.5(PRKAR1A):​c.709-209G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 523,032 control chromosomes in the GnomAD database, including 5,749 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1707 hom., cov: 32)
Exomes 𝑓: 0.14 ( 4042 hom. )

Consequence

PRKAR1A
NM_002734.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.214

Publications

7 publications found
Variant links:
Genes affected
PRKAR1A (HGNC:9388): (protein kinase cAMP-dependent type I regulatory subunit alpha) cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. This gene encodes one of the regulatory subunits. This protein was found to be a tissue-specific extinguisher that down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in this gene cause Carney complex (CNC). This gene can fuse to the RET protooncogene by gene rearrangement and form the thyroid tumor-specific chimeric oncogene known as PTC2. A nonconventional nuclear localization sequence (NLS) has been found for this protein which suggests a role in DNA replication via the protein serving as a nuclear transport protein for the second subunit of the Replication Factor C (RFC40). Several alternatively spliced transcript variants encoding two different isoforms have been observed. [provided by RefSeq, Jan 2013]
PRKAR1A Gene-Disease associations (from GenCC):
  • Acrodysostosis 1 with or without hormone resistance
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • acrodysostosis with multiple hormone resistance
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • Carney complex, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pigmented nodular adrenocortical disease, primary, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
  • acrodysostosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Carney complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial atrial myxoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary pigmented nodular adrenocortical disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-68527631-G-A is Benign according to our data. Variant chr17-68527631-G-A is described in ClinVar as Benign. ClinVar VariationId is 677028.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKAR1ANM_002734.5 linkc.709-209G>A intron_variant Intron 7 of 10 ENST00000589228.6 NP_002725.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKAR1AENST00000589228.6 linkc.709-209G>A intron_variant Intron 7 of 10 1 NM_002734.5 ENSP00000464977.2

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22381
AN:
151738
Hom.:
1706
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.153
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.172
Gnomad SAS
AF:
0.199
Gnomad FIN
AF:
0.106
Gnomad MID
AF:
0.0796
Gnomad NFE
AF:
0.134
Gnomad OTH
AF:
0.139
GnomAD4 exome
AF:
0.144
AC:
53392
AN:
371174
Hom.:
4042
Cov.:
4
AF XY:
0.147
AC XY:
29188
AN XY:
198102
show subpopulations
African (AFR)
AF:
0.174
AC:
1862
AN:
10686
American (AMR)
AF:
0.166
AC:
2624
AN:
15804
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
1305
AN:
11340
East Asian (EAS)
AF:
0.168
AC:
4212
AN:
25118
South Asian (SAS)
AF:
0.190
AC:
8078
AN:
42620
European-Finnish (FIN)
AF:
0.108
AC:
2112
AN:
19582
Middle Eastern (MID)
AF:
0.100
AC:
158
AN:
1574
European-Non Finnish (NFE)
AF:
0.135
AC:
30070
AN:
223422
Other (OTH)
AF:
0.141
AC:
2971
AN:
21028
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
2298
4597
6895
9194
11492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.147
AC:
22384
AN:
151858
Hom.:
1707
Cov.:
32
AF XY:
0.148
AC XY:
10944
AN XY:
74172
show subpopulations
African (AFR)
AF:
0.171
AC:
7068
AN:
41414
American (AMR)
AF:
0.158
AC:
2418
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
417
AN:
3466
East Asian (EAS)
AF:
0.171
AC:
881
AN:
5156
South Asian (SAS)
AF:
0.198
AC:
955
AN:
4818
European-Finnish (FIN)
AF:
0.106
AC:
1112
AN:
10488
Middle Eastern (MID)
AF:
0.0822
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
0.134
AC:
9081
AN:
67932
Other (OTH)
AF:
0.137
AC:
289
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
981
1962
2944
3925
4906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.138
Hom.:
6297
Bravo
AF:
0.154
Asia WGS
AF:
0.189
AC:
656
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
12
DANN
Benign
0.90
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3785905; hg19: chr17-66523772; COSMIC: COSV104423104; API